Combining cognitive rehabilitation and therapy to help patients with post-COVID cognitive issues and depression
Official title: Integrated Cognitive Rehabilitation and Cognitive Behavioral Therapy Intervention for patients with Post-COVID-19 Cognitive Impairment and Depression
Funded at Icahn School of Medicine at Mount Sinai · NIH-11055114 · Data updated 2026-11-12
This study is looking to create and try out a new program that helps people who are feeling forgetful and down after having COVID-19, making sure it works well for everyone, no matter their background.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | December 1, 2024 |
| Project end | November 30, 2029 |
| Funding year | 2025 |
| Award (this year) | $194,157 |
| NIH project number | 1K23MH136367-01A1 |
| Project ID | NIH-11055114 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults over 21 who are experiencing cognitive impairment and depression as a result of COVID-19.
✕Less likely to help
Patients who do not have cognitive impairment or depression related to COVID-19 may not benefit from this research.
What this research studies
This research aims to develop and test a new intervention that combines cognitive rehabilitation and cognitive behavioral therapy specifically for patients experiencing cognitive impairment and depression after COVID-19. The approach will be tailored to meet the needs of ethnoculturally diverse patients, ensuring that the intervention is relevant and effective for a wide range of individuals. The research will involve gathering insights from patients through focus groups and interviews to refine the intervention, followed by a pilot trial to assess its feasibility and initial effectiveness.
Why it matters
Potential benefit: If successful, this research could significantly improve cognitive function and mental health for patients suffering from post-COVID cognitive impairment and depression.
How similar studies have gone: Previous research has shown promise in using cognitive rehabilitation and therapy for cognitive and mental health issues, suggesting that this integrated approach could be effective.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Becker, Jacqueline Helcer — Icahn School of Medicine at Mount Sinai
- Study coordinator: Becker, Jacqueline Helcer
Related research
Other NIH-funded projects on the same topics.
-
Blocking a blood-vessel protein to protect the brain after COVID-19
Researchers are testing whether a drug that blocks the alpha5beta1 integrin can protect the brain and reduce memory and thinking problems after COVID-19 or in people with vascular dementia.
-
Insomnia, Depression, and Sleep Medications in Mild Cognitive Impairment Leading to Dementia
This project looks at how sleep problems and depression, along with the medicines used to treat them, may affect the progression from mild cognitive issues to dementia in older adults.
-
Improving depression care for Veterans during and after COVID-19
This study is looking at how to better spot and treat depression in Veterans, especially since the COVID-19 pandemic changed how care is delivered, and it involves nurses checking in with Veterans and doctors offering support based on their needs.
-
Using AI to assess social interaction and depression in older adults with mild cognitive impairment
This study is looking at how smart technology can help understand social interactions and mental health in older adults with mild cognitive impairment by watching videos and listening to conversations, so we can better track changes in their social life and feelings over time.
-
Automated diagnosis of mild cognitive impairment and depression in older adults
This study is working on a new tool to help doctors better diagnose mild cognitive impairment and late-life depression in people aged 65 and older, using both mobile apps and traditional tests to make sure everyone gets the best care possible.
-
Exploring how a specific protein affects cognitive issues related to COVID-19 in older adults
This study is looking at how COVID-19 might lead to memory and thinking problems in older adults with vascular dementia, and it will test if a special treatment can help improve their brain function by blocking a specific protein.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.